- Included in Dow Jones Sustainability World Index (DJSI World) and Dow Jones Sustainability Europe Index (DJSI Europe) for fourth and fifth consecutive years respectively
- Reflects Grifols standing as sustainability leader in light of its commitment to human rights, supply chain management, climate change management as well as health and safety
Grifols, a global healthcare company and leading manufacturer of plasma-derived medicines, today announced it is the number one biotechnology company in the S&P Dow Jones Sustainability Indices (DJSI), ascending to the top position in its fifth straight year of inclusion in the prestigious indices.
This recognition strengthens Grifols’ stature as a global leader in sustainability practices and comes as the company achieved its highest-ever S&P Global Corporate Sustainability Assessment (CSA) score. Grifols earned a rating of 70 points, marking a seven-point increase over last year's results and highlighting the company’s significant progress and unwavering commitment to sustainability.
In its climb to the top, Grifols has continuously raised its excellence in environmental, social and governance (ESG) practices. As the company advances its sustainability goals, it remains focused on driving long-term value and making a lasting impact toward a more sustainable, ethical and resilient future for all stakeholders.
The Dow Jones Sustainability Index comprises global sustainability leaders identified by S&P Global via the Corporate Sustainability Assessment, an annual evaluation that compares companies across 62 industries. This year, over 13,000 companies were invited to participate, with the index representing the top 10% of the largest 2,500 companies in the S&P Global Broad Market Index.
“It is an honor for Grifols to once again be recognized in the Dow Jones Sustainability Index as one of the world’s most sustainable companies,” said Nacho Abia, Grifols CEO. “As we continue to deliver consistently strong financial and operational performance, we are very much focused on our commitment to achieving best-in-class ESG practices and our 2030 goals.”
Acknowledgments from S&P Global
S&P Global has commended Grifols for its progress across ESG categories, including climate strategy, governance and risk management. While Grifols continues to accelerate its transition to a low-carbon economy, DJSI acknowledges Grifols’ efforts to foster a more responsible and sustainable supply chain, and awards it the highest scores for its sustainability reporting and business ethics.
On social strategy, S&P Global recognized Grifols’ dedication to maintaining a safe and healthy workplace for all employees and its commitment to upholding human rights across all operations. In addition, S&P has once again awarded the company the highest possible score for its commitment to ethical marketing.
For more information on Grifols’ ESG initiatives and progress, please visit Sustainability | Grifols and read more about the company’s commitment in the Biopharmaceutical Industry Sustainability Report | Grifols
